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Macroautophagy (herein autophagy) is an evolutionarily 
conserved process, requiring the gene ATG5, by which cells degrade 
cytoplasmic constituents and organelles.  Here we show that ATG5 
is required for efficient B cell development and for the maintenance 
of B-1a B cell numbers. Deletion of ATG5 in B lymphocytes using 
Cre-LoxP technology or repopulation of irradiated mice with 
ATG5-/- fetal liver progenitors resulted in a dramatic reduction 
in B-1 B cells in the peritoneum. ATG5-/- progenitors exhibited 
a significant defect in B cell development at the pro- to pre-B cell 
transition, although a proportion of pre-B cells survived to populate 
the periphery.  Inefficient B cell development in the bone marrow 
was associated with increased cell death, indicating that ATG5 is 
important for B cell survival during development. In addition, 
B-1a B cells require ATG5 for their maintenance in the periphery. 
We conclude that ATG5 is differentially required at discrete stages 
of development in distinct, but closely related, cell lineages. 
Introduction
Autophagy is a cellular process in which cytoplasm and cyto-
plasmic organelles are enveloped in double-membrane bound 
vesicles (autophagosomes) for deliv ry to the lysosome and subse-
quent degradation.1,2 Formation of the autophagosome requires the 
action of two evolutionarily conserved ubiquitin-like conjugation 
systems, both of which require the ATG5 gene.3,4 One system effi-
ciently generates ATG5-ATG12 conjugates that associate with the 
elongating isolation membrane during autophagosome formation, 
the other modifies the free C-terminal glycine of ATG8/LC3 with 
phosphatidylethanolamine.4 The unconjugated form of ATG8/LC3 
(LC3-I) can be distinguished from the lipidated form (LC3-II) by 
mobility in electrophoretic gels, providing one commonly used 
assay for autophagic activity. As mice lacking ATG5 die shortly after 
birth,5 conditional knockout alleles of ATG5 have been generated 
[ATG5flox/flox].6
Autophagy and autophagy genes have a role in multiple aspects of 
eukaryotic biology including survival during stress and growth factor 
withdrawal,1,5,7 tumor suppression,8-11 development,1,12,13 neuro-
degeneration,6,14 innate host defense,15-18 antigen presentation,19-21 
and T cell homeostasis.22 Because there are well-defined stages of 
lymphocyte development and function, the immune system presents 
a unique opportunity to study the role of autophagy and autophagy 
genes in normal cellular physiology. Pua et al. demonstrated that 
ATG5 is essential for T cell survival and proliferation.22 The require-
ment for ATG5 in B cell development remains to be addressed.
B cells are classified into two subsets, B-1 and B-2, based on cell 
surface marker expression, developmental origin, and functional 
properties.23 B-2 B cells develop from hematopoietic stem cells in the 
bone marrow, undergoing a series of maturational stages that can be 
defined by expression of cell surface markers (Hardy fractions A-F).24 
B-1 B cells are part of the innate immune system and are subdivided 
into B-1a and B-1b subsets based on expression of the cell surface 
protein CD5.23 The developmental origin of B-1 B cells is still 
controversial, with two competing models under study. According to 
the selection model, B-1 and B-2 B cells are derived from a common 
progenitor that differentiates into one of the two lineages based on 
antigen selection at the transitional stage.25 Alternatively, the lineage 
model proposes that B-1 and B-2 B cells originate from distinct 
progenitors. The lineage model is supported by the recent identifi-
cation of a B-1 B cell progenitor in fetal and adult tissues.26 It has 
also recently been suggested that B-1a and B-1b B cells have distinct 
progenitors and lineages.27
In this paper we evaluated the role of ATG5 in B cell development. 
While B-2 B cells can be generated from ATG5‑/‑ precursor cells 
and populate peripheral lymphoid organs, ATG5 was required for 
efficient development from pro- to pre-B cells in the bone marrow. 
The absence of ATG5 was associated with a significant increase in 
the death of Hardy fraction D-F B cells. In addition to its function 
during development, ATG5 is important for the maintenance of B-1a 
B cells in peripheral tissues. The autophagy gene ATG5 and an intact 
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autophagy pathway are required at specific stages in B cell develop-
ment and differentially required for distinct, but closely related, cell 
lineages.
Materials and Methods
Mice. ATG5‑/‑ and ATG5flox/flox mice have been described.5,6 
C.129P2-Cd19tm1(cre)Cgn/J (CD19-cre) mice, B6.129S7-Rag1tm1Mom/
J (RAG1‑/‑) mice, and B6.SJL-Ptprca Pepcb/BoyJ (CD45.1) mice were 
obtained from The Jackson Laboratory (Bar Harbor, ME). We compared 
ATG5flox/flox-CD19-Cre mice to CD19-Cre mice and littermate 
ATG5flox/flox mice throughout these experiments. Mice were genotyped 
as described,6 with the ATG5 gene detected with the primers exon3-1 
(GAATATGAAGGCACACCCCTGAAATG), short2 (GTACTGCA
TAATGGTTTAACTCTTGC), and check2 (ACAACGTCGAGCA
CAGCTGCGCAAGG) using PCR [94°C (4 min); 30 cycles of 94°C 
(30 sec), 60°C (30 sec), 72°C (1 min); 72°C (5 min)]. The Cre gene 
was detected with primers cre1 (AGGTTCGTTCACTCATGGA) 
and cre2 (TCGACCAGTTTAGTTACCC) using PCR [94°C 
(4 min); 25 cycles of 94°C (30 sec), 60°C (30 sec), 72°C 
(1 min); 72°C (5 min)]. CD45.1 chimeric mice were generated 
as described.22 For the generation of RAG1‑/‑ chimeric mice, day 
15.5–18.5 ATG5+/- x ATG5+/- fetuses were harvested and genotyped 
with the REDExtract-N-AmpTM Tissue PCR Kit (Sigma-Aldrich, 
St. Louis, MO). Sublethally irradiated (600 rad) RAG1‑/‑ hosts were 
injected with cells from one-fourth of a fetal liver. Chimeric mice 
were analyzed at least 6 weeks after reconstitution. All animal studies 
were performed in accordance with institutional policies for animal 
care and usage.
Flow cytometry. Single-cell suspensions were prepared from the 
bone marrow, lymph nodes, spleens, and thymi while peritoneal cells 
were harvested by lavage.28 Cells were stained and data collected on a 
FACSCalibur cytometer (BD Biosciences, San Jose, CA) for analysis 
using FlowJo software (TreeStar, Ashland, OR). Antibodies against 
IgM, IgD, TCRb, B220, BP-1, CD4, CD5, CD8, CD19, CD21, 
CD23, CD24 and CD43 were from BD Biosciences (San Jose, CA), 
eBioscience (San Diego, CA), or Southern Biotech (Birmingham, 
AL). Biotinylated antibodies were detected with streptavidin-PE-Cy7 
or streptavidin-APC (BD Biosciences, San Jose, CA). Annexin-V 
and 7-AAD staining (BD Biosciences, San Jose, CA) was as per the 
manufacturer’s instructions except that DMEM was used in place of 
1x Binding Buffer. All samples were gated by forward and side scatter 
on lymphocyte populations for analysis.
Immunoblots. B cells were purified using CD19-conjugated 
microbeads (Miltenyi, Auburn, CA). CD19-purified B cells and 
CD19 negative cells that did not bind to CD19-conjugated magnetic 
beads were lysed in 2x Laemmli buffer and subjected to western 
blotting using antibodies specific for ATG53 (1:1000 dilution), LC3 
(Novus Biologicals, Littleton, CO) (1:3000 dilution), and b-actin 
(Sigma-Aldrich, St. Louis, MO) (1:5000 dilution). Immunoblots 
were developed with HRP-conjugated secondary antibodies (Jackson 
Immunoreseach Laboratories, West Grove, PA) (1:10,000 dilu-
tion) and visualized by chemiluminescence (Amersham Biosciences, 
Pittsburgh, PA).
Statistical analyses. All data were analyzed with Prism software 
(GraphPad, San Diego, CA) using two-tailed unpaired t tests. Error 
bars represent SEM.
Results
ATG5 is required to maintain normal numbers of peripheral 
B-1 B cells. To study the role of the autophagy gene ATG5 in B 
cells, we generated ATG5‑/‑ chimeric mice. ATG5‑/‑ or wild type fetal 
liver cells were used to reconstitute irradiated RAG1‑/‑ hosts.29 In the 
peritoneum, ATG5-/- reconstituted mice had decreased numbers of 
B-1a B cells (16 fold), B-1b B cells (4 fold), and B-2 B cells (6 fold) 
(Fig. 1A and B). Lymph node B-2 B cell repopulation was equivalent 
between wild type and ATG5‑/‑ chimeras, while both B-1 and B-2 
B cell numbers were decreased in the spleen approximately 50% 
(B-2 B cells: p = 0.017; B-1 B cells: p = 0.035). The proportions 
of transitional, mature follicular, and marginal zone B-2 B cells in 
the spleen were normal, however (Fig. 1C). These data indicate that 
ATG5 has a role in maintaining both B-1 and B-2 B cell numbers in 
the periphery, with a more dramatic role in B-1a B cells.
ATG5 is required for the survival of pre-B cells. The observed 
decrease in peripheral B cells in ATG5‑/‑ chimeras could be due to a 
decrease in B cell production in the bone marrow or an increase in 
cell death in the periphery. To test the first hypothesis, we evaluated 
the stages of bone marrow B cell development in ATG5‑/‑ versus wild 
type fetal-liver reconstituted irradiated CD45.122 and RAG1‑/‑ hosts 
(Fig. 2). FACS analysis of donor pro-B cells from CD45.1 chimeras 
revealed no significant differences in cell numbers of fraction A–C' 
developing B cells (Fig. 2A and B). Analysis of ATG5‑/‑ RAG1‑/‑ 
chimeric mice revealed a decrease in Hardy fractions D (3.7 fold), 
E (8.3 fold), and F (11.8 fold) (Fig. 2C and D). CD45.1 chimeras 
had a similar deficiency of fractions D, E, and F (data not shown). 
These data indicate that ATG5 has a critical role in the final stages 
of bone marrow B cell development. We hypothesized that ATG5 
may be required for B cell survival after the pro-B cell stage of 
development. FACS analysis of freshly isolated bone marrow cells 
revealed a greater percentage of fraction D-F cells were dead or dying 
in ATG5‑/‑ RAG1‑/‑ chimeric mice compared with control mice as 
measured by Annexin-V and 7-AAD (Fig. 2E; ATG5+/+: 3.2 ± 0.8%; 
ATG5-/-: 22.2 ± 5.3%; p = 0.0056). We conclude that ATG5 is 
required as a survival factor after the pro-B to pre-B cell transition 
in the bone marrow.
B-2 B cells survive normally in the periphery without ATG5. 
Although the role of ATG5 in B cell development could explain 
the deficiency in peripheral ATG5‑/‑ B cells, we could not rule out 
that ATG5 is also required for B cell survival in the periphery. To 
determine if ATG5 is required for B cell homeostasis without the 
confounding role of ATG5 in B cell development, we expressed 
Cre recombinase in the B cells of mice containing two copies of 
a knock-in ATG5 gene in which LoxP sites were inserted flanking 
the third exon [ATG5flox/flox].6 B cell specific expression of Cre was 
obtained using the B-cell specific CD19 promoter [CD19-Cre].30 
Although the expression of Cre from the CD19 promoter effectively 
deletes loxP-flanked DNA in more than 90–95% of mature B cells, 
it results in incomplete DNA rearrangement in pre-B cells.30 Given 
that the CD19-Cre construct replaces the wild type CD19 gene and 
could therefore have an effect on B cells independent of the deletion 
of ATG5,31 all mice were bred to have only one copy of CD19-Cre. 
Furthermore, we used ATG5 wild type CD19-Cre mice (herein 
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We confirmed rearrangement of the ATG5flox/flox allele specifically 
in CD19+ B cells from ATG5flox/flox-CD19-Cre mice using PCR 
(data not shown). In addition, B cells from ATG5flox/flox-CD19-Cre 
mice did not express detectable ATG5-ATG12 conjugate and failed 
to convert LC3-I to LC3-II (Fig. 3A). Splenic B cells from control 
ATG5flox/flox mice expressed ATG5-ATG12 conjugate and converted 
LC3-I to LC3-II (Fig. 3A). We conclude that ATG5 is specifically 
deleted from peripheral CD19+ B lymphocytes in our mice and that, 
as expected,4 loss of ATG5 results in defective autophagy as shown by 
loss of the capacity to generate LC3-II from LC3-I.
We next determined whether ATG5 is required to maintain normal 
numbers of B cells in peripheral tissues of adult mice. Importantly, we 
observed no difference in B cell development in fractions A through 
E in ATG5flox/flox-CD19-Cre mice (data not shown). There was a 
two fold decrease in fraction F cells in ATG5flox/flox-CD19-Cre mice 
compared with ATG5flox/flox controls (ATG5flox/flox: 1.6 ± 0.27 x 106; 
ATG5flox/flox-CD19-Cre: 0.805 ± 0.164 x 106; p = 0.0243). This was 
consistent with, although less severe than, the decrease in fraction F 
cells observed in chimeric mice. There was no decrease in fraction F 
cells in CD19-Cre mice. In the periphery, ATG5flox/flox-CD19-Cre 
mice had normal numbers of B220+ B lymphocytes in the spleen 
and lymph nodes, and IgM and IgD were expressed normally on 
these cells. The percentage and number of splenic and lymph node 
mature recirculating B cells and transitional B cells was comparable 
between ATG5flox/flox, ATG5flox/flox-CD19-Cre, and CD19-Cre mice 
(Fig. 3B). As expected, there were no differences in the numbers of 
T cell subsets in the thymus or periphery in these mice (data not 
shown). As more than 95% of splenic and nearly 100% of lymph 
node B cells are B-2 B cells,32 it follows that B-2 B cell numbers are 
normal in the spleen and lymph node in the absence of ATG5. To 
determine if ATG5 is required for the in vivo survival of mature B 
cells, we evaluated Annexin-V and 7-AAD staining of freshly isolated 
splenic and lymph node B220+ cells and observed no differences in 
the numbers of dead or dying B cells (data not shown). These data 
indicate that ATG5 is not essential for the maintenance of B-2 B cell 
populations in the periphery and suggest that the decrease in splenic 
B-2 B cells in ATG5‑/‑ chimeric animals is due to a requirement of 
ATG5 for efficient development.
ATG5 is required in a cell-intrinsic manner to maintain normal 
numbers of B-1a B cells. In contrast to these findings for B-2 B 
cells, ATG5flox/flox-CD19-Cre mice showed a 5-fold decrease in the 
number of B-1a B cells in the peritoneum (Fig. 4A; ATG5flox/flox: 
4.5 ± 1.2 x 105; ATG5flox/flox-CD19-Cre: 0.76 ± 0.19 x 105; p = 
0.0079). Although there was a trend towards decreased B-1b and 
B-2 B cell numbers in ATG5flox/flox-CD19-Cre mice, there was no 
statistically significant difference in the number of B-1b or B-2 B 
cells in the peritoneum. There was also no decrease in B-1a B cell 
numbers in CD19-Cre mice (Fig. 4A). One explanation for this 
finding would be that ATG5 is required for expression of CD5, a 
marker of B-1a B cells. In the peritoneum, both B-1a and B-1b B 
cells are B220lo, IgMhi, IgDlo, CD11b+, CD43+, and CD23-.32 We 
therefore analyzed expression of IgD, IgM, and CD23 on peritoneal 
B cells (Fig. 4B and C). We found that ATG5flox/flox-CD19-Cre mice 
contained fewer B-1 B cells in the peritoneum than ATG5flox/flox 
or CD19-Cre mice, confirming that the deficiency of B-1a B cells 
shown using CD5/B220 staining was not an artifact due to lack of 
CD5 expression in ATG5 deficient cells. In addition, we confirmed 
Figure 1.  B-1 B cells are deficient in ATG5-/- chimeric mice. (A) Staining 
of peritoneal cells from ATG5+/+ and ATG5-/- RAG1-/- chimeric mice to 
identify B cell subsets: B-1a (CD5+, B220lo); B-1b (CD5-, B220lo); B-2 
(CD5-, B220hi). Numbers indicate percentage of cells in each gate.  Data 
representative of at least seven mice from four independent experiments. 
(B) Quantitation of B-1 B cells from the peritoneum of ATG5+/+ and ATG5-/- 
RAG1-/- chimeric mice (ATG5+/+: n = 7; ATG5-/-: n = 6). (C) IgM/IgD and 
CD21/CD23 staining of B220+ lymphocytes from the spleens of ATG5+/+ 
and ATG5-/- RAG1-/- chimeric mice to identify B cell subsets: M, mature B 
cells (IgMlo, IgDhi); T1, transitional type 1 (IgMhi, IgDlo); T2, transitional type 
2 (IgMhi, IgDhi) ; MZ, marginal zone B cells (CD21hi, CD23lo); FO, follicular 
B cells (CD21lo, CD23hi). T1 gating includes marginal zone and splenic B-
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that this deficiency is specific for B-1a B cells but not B-1b B cells 
(Fig. 4C). We conclude that ATG5 is required for the maintenance 
of B-1a B cells but not B-1b or B-2 B cells in peripheral tissues, 
providing a surprising differential requirement for an autophagy gene 
between three closely related cell lineages. In addition, the require-
ment for ATG5 to maintain B-1a B cell numbers is cell-intrinsic 
since only B cells lack ATG5 in ATG5flox/flox-CD19-Cre mice. This 
suggests that the observed results in ATG5‑/‑ chimeric mice may also 
be due to cell intrinsic effects of ATG5 deficiency.
Discussion
In this paper we demonstrate a critical role for the autophagy gene 
ATG5 in specific B cell developmental stages and lineages. ATG5 is 
required for the efficient development and survival of pre-B cells in 
Figure 2. ATG5 is required for the normal development of pre-B cells in the bone marrow. (A) Flow cytometry of bone marrow cells from ATG5+/+ and 
ATG5‑/‑ CD45.1 chimeric mice. Cells were gated on CD45.2+, GR1-, Mac1- and 7-AAD-. B220+, CD43+ cells were further analyzed for expression of 
BP-1 and CD24. Data representative of at least four mice from four independent experiments. (B) Quantitation of Hardy fractions A-C' in ATG5+/+ and 
ATG5‑/‑ CD45.1 chimeric mice (n = 4 for each group). (C) Flow cytometry of bone marrow cells from ATG5+/+ and ATG5‑/‑ RAG1‑/‑ chimeric mice. Cells 
were gated on B220+, CD43- and analyzed for expression of IgM. Data representative of at least eight mice from four independent experiments. (D) 
Quantitation of Hardy fractions D–F in ATG5+/+ and ATG5‑/‑ RAG1‑/‑ chimeric mice (n = 8 for each group). (E) Flow cytometry of freshly isolated bone 
marrow cells from ATG5+/+ and ATG5‑/‑ RAG1‑/‑ chimeric mice. Cells were gated on B220+, CD43- and analyzed for cell death by Annexin-V and 7-AAD. 
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the bone marrow. A few B-2 B cells survive this transition and are 
able to populate peripheral lymphoid tissues. In the absence of ATG5 
there is also a dramatic reduction in peripheral B-1a B cells.
The requirement for ATG5 in autophagy is clear.3,4 Therefore, we 
can safely conclude from our studies in ATG5flox/flox-CD19-Cre mice 
that autophagy is not required for the maintenance of peripheral 
mature B-2 B cell numbers. However, it has recently been reported 
that ATG5 may have other roles in addition to its primary role in 
autophagy.33 ATG5 can be cleaved by calpain and gain pro-death 
activity.34 The protein can also interact with Fas-associated protein 
with death domain (FADD) to trigger autophagic cell death.35 We 
believe it unlikely that these pro-death roles of ATG5 are related to 
our findings in which ATG5 is required for the survival of B cells.
Our results, in conjunction with the ATG5‑/‑ T cell charac-
terization by Pua et al,22 demonstrate that ATG5 is differentially 
required in T cells versus B cells, two cell types from a common 
developmental lineage. We have shown that ATG5 is required for the 
maintenance of B-1a B cells, but not B-1b or B-2 B cells. Recently 
it has been suggested that B-1a, B-1b, and B-2 B cells may develop 
from distinct cell lineages.26,27 If so, then our results suggest that 
these distinct lineages have differential requirements for ATG5 and 
ATG5-dependent autophagy. Additional studies assessing the basal 
levels of autophagy in wild type B-1a B cells would be useful. In addi-
tion, our data suggest that ATG5‑dependent autophagy is required 
at very specific stages in lymphocyte development. This is perhaps 
surprising for a cellular process that is observed in essentially all cells 
and that is conserved through evolution.
It is intriguing to speculate that the critical role for ATG5 in the 
maintenance of B-1a B cells in the periphery and for efficient pro-B 
cell to pre-B cell transition during B-2 B cell development in the 
bone marrow are related phenomena. B-1a B cells maintain their 
Figure 3. B-2 B cells from ATG5flox/flox-CD19-Cre mice do not express 
ATG5 but are present in normal numbers. (A) Immunoblotting against ATG5 
and LC3 from CD19+ (B) and CD19- (Other) bead-purified splenocytes. 
Representative blot of three independent experiments. (B) IgM and IgD stain-
ing of B220+ lymphocytes from the spleen and lymph nodes. M, mature B 
cells (IgMlo, IgDhi); T1, transitional type 1 (IgMhi, IgDlo); T2, transitional type 
2 (IgMhi, IgDhi). T1 gating includes marginal zone and splenic B-1 B cells. 
Data representative of at least ten mice from five independent experiments.
Figure 4. B-1a B cells are deficient in ATG5flox/flox-CD19-Cre mice. Staining 
of peritoneal cells to identify B cell subsets: B-1a (CD5+, B220lo, CD23-, 
IgMhi, IgDlo); B-1b (CD5-, B220lo, CD23-, IgMhi, IgDlo); B-2 (CD5-, B220hi, 
CD23lo, IgMlo, IgDhi). All data is representative of at least five mice from 
three independent experiments. (C) B-1 B cells are gated by B220lo, CD23- 
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numbers in the adult by self-renewal.36 We speculate that B-1a B 
cells lacking ATG5 may not be able to self-renew efficiently resulting 
in decreased peripheral numbers. In this case the effects of ATG5 on 
B-2 and B-1a B cells may reflect a critical role for ATG5 in survival 
during specific stages of cellular differentiation. Given the role of 
cytokines and growth factors in B cell development, this might be 
due to a role for ATG5 in cytokine-driven differentiation or cell 
survival after growth factor withdrawal.7
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